330 related articles for article (PubMed ID: 32429376)
1. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
3. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
5. Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis.
Hsu FT; Liu WL; Lee SR; Jeng LB; Chen JH
Phytomedicine; 2023 Oct; 119():154947. PubMed ID: 37549536
[TBL] [Abstract][Full Text] [Related]
6. Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
Lee YC; Weng YS; Wang HY; Hsu FT; Chueh FS; Wu JY; Chen WL; Chen JH
Anticancer Res; 2022 Aug; 42(8):3825-3833. PubMed ID: 35896265
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
8. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
[TBL] [Abstract][Full Text] [Related]
9. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
[TBL] [Abstract][Full Text] [Related]
10. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
11. Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Li CH; Ku MC; Lee KC; Yueh PF; Hsu FT; Lin RF; Yang CC; Wang WC; Chen JH; Hsu LC; Lee YH
Anticancer Res; 2022 Sep; 42(9):4403-4410. PubMed ID: 36039427
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells.
Ou HC; Chou FP; Sheu WH; Hsu SL; Lee WJ
Arch Toxicol; 2007 Jun; 81(6):421-32. PubMed ID: 17216433
[TBL] [Abstract][Full Text] [Related]
13. High concentration of magnolol induces hepatotoxicity under serum-reduced conditions.
Kao YH; Jawan B; Sun CK; Goto S; Lin YC; Hung CT; Pan MC; Hsu LW; Cheng YF; Lai CY; Wang CS; Tsai CC; Chang HR; Chen CL
Phytomedicine; 2010 May; 17(6):469-74. PubMed ID: 19683908
[TBL] [Abstract][Full Text] [Related]
14. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
15. Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.
Chunlian W; Heyong W; Jia X; Jie H; Xi C; Gentao L
Inflammation; 2014 Dec; 37(6):1957-67. PubMed ID: 24893579
[TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
17. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
[TBL] [Abstract][Full Text] [Related]
18. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
Chiang CH; Chung JG; Hsu FT
Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
[TBL] [Abstract][Full Text] [Related]
19. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
[TBL] [Abstract][Full Text] [Related]
20. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli C; Guillermo R; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
BMC Cancer; 2011 Oct; 11():456. PubMed ID: 22014088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
